Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Free Cash Flow (2024 - 2025)

BioAge Labs (BIOA) has disclosed Free Cash Flow for 2 consecutive years, with -$28.4 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow fell 449.24% to -$28.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$82.3 million through Dec 2025, down 58.7% year-over-year, with the annual reading at -$82.3 million for FY2025, 58.7% down from the prior year.
  • Free Cash Flow hit -$28.4 million in Q4 2025 for BioAge Labs, down from -$16.1 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$5.2 million in Q4 2024 to a low of -$28.4 million in Q4 2025.